KIMBERLY STABINGAS: Open Payments
NPI 1457637282 · WAKE FOREST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$383 in 15 payments from 8 companies in 2025. Trend: 2023 $247 · 2024 $114 · 2025 $383
Food & beverage: $383
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $117 |
| ABBVIE INC. | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Novo Nordisk Inc | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, SPRAVATO, Wegovy, VRAYLAR, UBRELVY, BREZTRI, INGREZZA, XIFAXAN.
Industry payments across NC — which companies pay providers there.
